Subtopic Deep Dive
IGF-1 Receptor Knockout Models
Research Guide
What is IGF-1 Receptor Knockout Models?
IGF-1 Receptor Knockout Models are genetically engineered mice with targeted null mutations in the Igf1r gene to study the physiological roles of the type 1 insulin-like growth factor receptor.
Igf1r null mice exhibit severe embryonic lethality and growth deficiency, as first demonstrated by Liu et al. (1993) with 2866 citations. Conditional tissue-specific knockouts reveal roles in metabolism, longevity, and cancer. Over 20 studies build on this foundational model.
Why It Matters
Igf1r knockout models prove IGF-1R essential for embryonic development and postnatal growth, linking pathway inhibition to extended lifespan in mice (Liu et al., 1993). They establish IGF-1R as a cancer target due to its anti-apoptotic effects (Baserga et al., 2003). These models guide therapies for growth disorders and neurodegeneration, with IGF-1 infusion rescuing hippocampal neurogenesis deficits (Åberg et al., 2000; Trejo et al., 2001).
Key Research Challenges
Embryonic Lethality
Global Igf1r null mice die at birth due to growth retardation, limiting postnatal studies (Liu et al., 1993). Conditional knockouts using Cre-lox systems address this but require tissue-specific validation. Heterozygotes show milder phenotypes for partial loss analysis.
Tissue-Specific Phenotypes
Interpreting metabolic and longevity effects demands precise Cre drivers to isolate IGF-1R roles from IGF-1 ligand effects (Firth and Baxter, 2002). Knockouts reveal muscle hypertrophy links but confound with GH interactions (Giustina et al., 2008). Validating receptor specificity remains critical.
Cancer-Longevity Tradeoff
Igf1r disruption extends lifespan yet alters tumor susceptibility, complicating therapeutic translation (Baserga et al., 2003). Models show anti-apoptotic IGF-1R inhibition protects against cancer but risks growth failure (Liu et al., 1993). Balancing these requires multi-omics integration.
Essential Papers
Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
Jeh-Ping Liu, Julie C. Baker, Archlbald S. Perkins et al. · 1993 · Cell · 2.9K citations
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Sue M. Firth, Robert C. Baxter · 2002 · Endocrine Reviews · 1.7K citations
In addition to their roles in IGF transport, the six IGF-binding proteins (IGFBPs) regulate cell activity in various ways. By sequestering IGFs away from the type I IGF receptor, they may inhibit m...
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Annamaria Colao, Diego Ferone, Paolo Marzullo et al. · 2004 · Endocrine Reviews · 1.3K citations
This review focuses on the systemic complications of acromegaly. Mortality in this disease is increased mostly because of cardiovascular and respiratory diseases, although currently neoplastic comp...
Intrauterine Growth Retardation and Postnatal Growth Failure Associated with Deletion of the Insulin-Like Growth Factor I Gene
Katie A. Woods, Cecilia Camacho‐Hübner, Martin O. Savage et al. · 1996 · New England Journal of Medicine · 1.1K citations
Insulin-like growth factor I (IGF-I) mediates the majority of the growth-promoting effects of growth hormone (GH) after birth.1 In the prenatal period, GH does not appear to have a major influence ...
Circulating Insulin-Like Growth Factor I Mediates Exercise-Induced Increases in the Number of New Neurons in the Adult Hippocampus
José Luís Trejo, Eva Carro, Ignacio Torres‐Alemán · 2001 · Journal of Neuroscience · 1.0K citations
Although the physiological significance of continued formation of new neurons in the adult mammalian brain is still uncertain, therapeutic strategies aimed to potentiate this process show great pro...
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Andrea Giustina, Gherardo Mazziotti, Ernesto Canalis · 2008 · Endocrine Reviews · 883 citations
GH and IGF-I are important regulators of bone homeostasis and are central to the achievement of normal longitudinal bone growth and bone mass. Although GH may act directly on skeletal cells, most o...
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Balázs Gereben, Ann Marie Zavacki, Scott Ribich et al. · 2008 · Endocrine Reviews · 855 citations
The iodothyronine deiodinases initiate or terminate thyroid hormone action and therefore are critical for the biological effects mediated by thyroid hormone. Over the years, research has focused on...
Reading Guide
Foundational Papers
Start with Liu et al. (1993, 2866 citations) for global knockout lethality; follow Firth and Baxter (2002, 1740 citations) for IGFBP interactions; Woods et al. (1996, 1089 citations) for human IGF-1 parallels.
Recent Advances
Baserga et al. (2003, 642 citations) on cancer biology; Giustina et al. (2008, 883 citations) on skeletal roles; Trejo et al. (2001, 1001 citations) for neurogenesis.
Core Methods
Homologous recombination for null alleles (Liu et al., 1993); Cre-lox for conditionals; phenotype analysis via growth curves, survival, histology.
How PapersFlow Helps You Research IGF-1 Receptor Knockout Models
Discover & Search
Research Agent uses searchPapers('Igf1r knockout mice embryonic lethality') to retrieve Liu et al. (1993, 2866 citations), then citationGraph reveals 20+ conditional knockout descendants like muscle-specific models. exaSearch('tissue-specific Igf1r Cre-lox longevity') uncovers Baserga et al. (2003) cancer links. findSimilarPapers on Liu et al. surfaces Firth and Baxter (2002) IGFBP modulation studies.
Analyze & Verify
Analysis Agent applies readPaperContent on Liu et al. (1993) to extract lethality phenotypes, then verifyResponse with CoVe cross-checks against Woods et al. (1996) IGF-1 deletion parallels. runPythonAnalysis processes citation networks in pandas to quantify model adoption (e.g., 2866 cites for global vs. conditional). GRADE grading scores evidence strength for lifespan claims from Baserga et al. (2003).
Synthesize & Write
Synthesis Agent detects gaps in neurodegeneration applications by flagging absent hippocampal Igf1r studies post-Trejo et al. (2001), then Writing Agent uses latexEditText to draft model comparisons and latexSyncCitations for Liu et al. (1993). latexCompile generates phenotype tables; exportMermaid diagrams signaling pathways from Firth and Baxter (2002).
Use Cases
"Extract growth data from Igf1r knockout papers and plot body weight curves"
Research Agent → searchPapers('Igf1r null mice growth') → Analysis Agent → readPaperContent(Liu et al. 1993) + runPythonAnalysis(pandas plot from extracted weights) → matplotlib figure of embryonic/postnatal deficits.
"Write LaTeX review on Igf1r muscle knockouts with citations"
Synthesis Agent → gap detection('muscle Igf1r conditional') → Writing Agent → latexGenerateFigure(phenotype diagram) → latexSyncCitations(Liu 1993, Giustina 2008) → latexCompile → PDF with synced refs and IGF-1R pathway mermaid.
"Find code for Igf1r mouse phenotype analysis"
Research Agent → searchPapers('Igf1r knockout') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → R script for survival curves from Baserga et al. (2003)-cited longevity data.
Automated Workflows
Deep Research workflow scans 50+ Igf1r papers via citationGraph from Liu et al. (1993), producing structured report on lethality-to-conditional evolution. DeepScan applies 7-step CoVe to verify cancer claims in Baserga et al. (2003) against Firth and Baxter (2002). Theorizer generates hypotheses on IGF-1R/IGFBP interactions for neurodegeneration from Trejo et al. (2001).
Frequently Asked Questions
What defines IGF-1 Receptor Knockout Models?
Genetically engineered mice with Igf1r null mutations, first created by Liu et al. (1993), showing 75% embryonic size reduction and lethality at birth.
What methods create conditional Igf1r knockouts?
Cre-loxP recombination targets tissue-specific deletion post-embryo, building on global nulls (Liu et al., 1993), to study adult phenotypes like longevity.
What are key papers on Igf1r knockouts?
Liu et al. (1993, Cell, 2866 citations) foundational; Baserga et al. (2003) on cancer; Firth and Baxter (2002) on IGFBP modulation (1740 citations).
What open problems exist in Igf1r models?
Resolving lifespan extension vs. cancer risk tradeoffs (Baserga et al., 2003); integrating multi-tissue conditionals with human IGF-1R mutations (Woods et al., 1996).
Research Growth Hormone and Insulin-like Growth Factors with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching IGF-1 Receptor Knockout Models with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.